Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 8, 2025 • 9:31 PM ET

Date/Time Source News Release
06/24/2025 07:00 AM EDT GlobeNewswire Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe
05/07/2025 07:00 AM EDT GlobeNewswire Amarin Reports First Quarter 2025 Financial Results
04/29/2025 04:15 PM EDT GlobeNewswire Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
04/28/2025 04:15 PM EDT GlobeNewswire Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
04/09/2025 07:30 AM EDT GlobeNewswire Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
04/07/2025 07:30 AM EDT GlobeNewswire Amarin Appoints JEC Capital Partners' Michael Torok to Board of Directors
03/31/2025 08:00 AM EDT GlobeNewswire Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist
03/12/2025 07:01 AM EDT GlobeNewswire Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program
03/12/2025 07:00 AM EDT GlobeNewswire Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action 
02/27/2025 09:00 AM EST GlobeNewswire Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering
Page

Additional News

As of July 8, 2025 • 9:31 PM ET

Date/Time Source News Release
07/02/2025 09:40 AM EDT Zacks Are Medical Stocks Lagging Amarin (AMRN) This Year?
07/01/2025 09:17 AM EDT Zacks Moderna Stock Gains on Encouraging Flu Vaccine Data
06/27/2025 10:00 AM EDT Zacks Best Momentum Stock to Buy for June 27th
06/25/2025 11:06 AM EDT Zacks Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU
06/25/2025 10:02 AM EDT Zacks Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag
06/25/2025 09:28 AM EDT Zacks Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock?
06/24/2025 07:40 AM EDT SeekingAlpha Amarin inks licensing deal with Recordati for lead drug Vazkepa
06/23/2025 12:34 PM EDT Zacks SNY Gets CHMP Nod for Expanded Use of Sarclisa in Multiple Myeloma
06/20/2025 09:46 AM EDT Zacks Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid
06/19/2025 11:11 AM EDT Zacks Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.